Clinical Trials
2 trialsNCT01990209 2022-06-30
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01808040 2019-11-18
A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
University of Wisconsin, Madison
Phase 1 Completed